Shenzhen, China. (SANEPR.com) November 7, 2007 -- Beike Biotechnology, (http://www.beikebiotech.com), the leader in stem cell applications for medical treatment, has announced that it has formally established a world-class laboratory facility for the research of cell reprogramming and gene engineering, through a joint agreement with the Shenzhen Graduate School of China’s renowned Tsinghua University. The lab will conduct research on stem cells, the nuclear transfer and reprogramming of cells, monoclonal antibodies known as “magic bullets” for treating disease and other scientifically exciting cell engineering innovations. The aim of the lab is to establish a global research hub that will hopefully someday provide breakthroughs in the way medical science seeks to treat diseases like cancer, Parkinson’s, and many other debilitating ailments.
Link
Stem cells and other advanced biological techniques belong to the world. No effort to stop a line of research in any one country could hope to do anything but slow down the search for answers. If the answers turn out to be of benefit to mankind, Efforts to stand in the way of that benefit are bound to fail.
Tags: Stem Cells, China, Tsinghua University, Beike
Powered by Qumana
No comments:
Post a Comment